Accuri C6 Flow Cytometer System
Originally published online as doi:10.1189/jlb.0905530 on April 14, 2006

Published online before print April 14, 2006
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Supplemental Data for jlb.0905530
Right arrow All Versions of this Article:
jlb.0905530v1
80/1/174    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Viemann, D.
Right arrow Articles by Roth, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Viemann, D.
Right arrow Articles by Roth, J.
(Journal of Leukocyte Biology. 2006;80:174-185.)
© 2006 by Society for Leukocyte Biology

TNF induces distinct gene expression programs in microvascular and macrovascular human endothelial cells

Dorothee Viemann*,{dagger},1, Matthias Goebeler{ddagger}, Sybille Schmid{ddagger}, Ursula Nordhues*, Kerstin Klimmek§, Clemens Sorg* and Johannes Roth*,{dagger}

* Department of Experimental Dermatology and Interdisciplinary Clinical Research Center and
§ Integrated Functional Genomics, University of Münster, Germany;
{dagger} Department of Pediatrics, University Hospital Münster, Germany; and
{ddagger} Department of Dermatology, University Hospital Mannheim, University of Heidelberg, Germany

1 Correspondence: Department of Experimental Dermatology, University of Münster, Röntgenstr. 21, 48149 Münster, Germany. E-mail: viemannd{at}uni-muenster.de


arrow
ABSTRACT
 
The relevance of the diversity of endothelial cells (ECs) for the response to inflammatory stimuli is currently not well defined. Using oligonucleotide microarray technique, we systematically analyzed the tumor necrosis factor (TNF)-induced expression profile in human microvascular ECs (HMEC) and macrovascular human umbilical vein ECs (HUVEC), analyzing 13,000 human genes by microarray analysis. Using strict inclusion and exclusion criteria, microarray analysis revealed that about half of the TNF-induced genes were specific for HMEC-1 or HUVEC. The microarray data could widely be confirmed by quantitative reverse transcriptase-polymerase chain reaction and at the protein level. It is interesting that the majority of those genes regulated depending on the cell type encoded for chemokines, cytokines, and cell surface molecules. Our results argue for a more careful consideration of specific effects restricted to distinct subtypes of ECs. The establishment of EC type-specific expression patterns may thus provide the basis for a selective manipulation of specific endothelial subtypes in different inflammatory diseases.

Key Words: gene regulation • inflammation • microarray


arrow
INTRODUCTION
 
Inflammatory processes are critically determined by the response of the vascular endothelium to extracellular injury. Distinct stimuli trigger gene expression programs, which result in the transcription of a characteristic battery of pro- and anti-inflammatory proteins. These molecules guide attraction and interaction with leukocytes or platelets, affect vascular permeability and coagulation, and finally, control the course and outcome of inflammatory reactions and determine the composition of the infiltrating leukocytes.

The diversity of the vascular bed is crucially determined by the type of endothelial cells (ECs) lining the inner vessel surface. In many studies, EC cultures are the basis for experimental designs investigating inflammatory reactions of endothelia to derive conclusions for vascular responses regarding inflammation. The most frequently used models to study micro- and macrovascular ECs in vitro are human microvascular ECs (HMEC) and macrovascular human umbilical vein ECs (HUVEC). However, results of studies based on a given EC type are sometimes transferred uncritically to other types of ECs [1 2 3 ]. Merely, E-selectin is stated frequently to be expressed differentially in HUVEC and HMEC-1, which suggests potential functional differences [4 ]. Nevertheless, it is tacitly assumed that the responses of both EC types to distinct inflammatory stimuli are basically comparable. Recent studies provided first evidence for differences in basal gene expression profiles of microvascular and macrovascular ECs [5 , 6 ]. So far, only one study exists, which compares the gene expression response of two different ECs (human blood/brain-barrier EC vs. HUVEC) upon stimulation with tumor necrosis factor (TNF) [7 ]. However, the validity of such data for individual genes is limited as a result of the small number of independent experiments and a limited statistical analysis. Such deficits generally result in a low rate of confirmation of microarray data by independent methods. It remains unclear whether differences in basal gene expression lead to an altered cellular response to distinct inflammatory stimuli in microvascular and macrovascular ECs or whether a potent inflammatory stimulus such as TNF indeed generates roughly comparable responses in both types of EC despite differences in basal gene expression. Characterizing and understanding the diversity of ECs therefore appear to be prerequisites for the interpretation of data obtained from in vitro models with regard to their relevance for inflammatory diseases in man.

We have recently determined the gene expression profile of HUVEC induced by TNF [8 ]. As such information is not available for HMEC-1, for the first time, we here characterize their gene expression response upon stimulation with TNF using oligonucleotide microarray technique. A high number of independent experiments, strict quality criteria, and an extensive statistical evaluation of 14 independent microarray analyses allowed us to reliably compare microvascular and macrovascular ECs. Besides many genes comparably induced in HMEC-1 and HUVEC, we identified a considerable number of others, which are regulated differentially by TNF, depending on the specific type of EC. It is surprising that cell type-dependent regulation showed only minor differences regarding genes involved in cell differentiation and cell cycle control but rather striking differences with respect to genes encoding chemokines, cytokines, and cell surface molecules.


arrow
MATERIALS AND METHODS
 
Cytokines and reagents
Human recombinant TNF-{alpha} was obtained from R&D Systems (Wiesbaden, Germany). All other reagents were purchased from Sigma-Aldrich (Deisenhofen, Germany) unless otherwise specified.

Cells and cell culture
HMEC-1 were kindly provided by Dr. Francisco Candal (Centers for Disease Control, Atlanta, GA). They were cultured at 37°C in 3% CO2 in MCDB131 (Biochrom, Berlin, Germany) supplemented with 10% fetal calf serum (FCS) gold (PAA Laboratories, Cölbe, Germany), 20 mM L-glutamine, 50 µg/ml (≥30 units/ml) gentamicin (Cytogen, Berlin, Germany), 10 ng/ml epidermal growth factor (EGF; Boehringer, Mannheim, Germany), and 1 µg/ml hydrocortisone (HC; Sigma-Aldrich). HUVEC were obtained from Clonetics (via Cell Systems, St. Katharinen, Germany) and cultured as described elsewhere [8 , 9 ]. HMEC-1 (after thawing) and HUVEC were used for exposure to TNF between Passages 3 and 4.

DNA microarray hybridization
HMEC-1 were exposed to medium as control or 2 ng/ml TNF for 5 h in three independent experiments. Total cellular RNA was isolated, processed, and hybridized to Affymetrix Human Genome 133 A Gene Chip arrays (Affymetrix, Santa Clara, CA) according to the manufacturer’s instructions. Fluorescence data were processed by the MicroArray Suite software 5.0 (Affymetrix). With respect to HUVEC, four independent experiments had been performed as described [8 ]. Fluorescence raw data of the hybridization were computed and statistically analyzed using the Expressionist Suite software package (GeneData, Basel, Switzerland) as described elsewhere [8 ]. The complete datasets are deposited in the Gene Expression Omnibus database [Accession Numbers GSE2638 (HMEC) and GSE2639 (HUVEC)].

Comparing TNF-stimulated HUVEC or HMEC-1 with their unstimulated controls, we considered genes with a fold-change of >2.5 or <–2.5 and a P value of <0.05 as expressed differentially. Regarding genes that were called present (on) or absent (off), we defined genes with "on:off" ratios of 3:0, 3:1, 2:0, 0:2, 1:3, and 0:3 between unstimulated to TNF-stimulated HMEC-1 as significantly regulated. On/off events were categorized in grades of expression over background as described before [8 ], and + = n-fold range 5–10; ++ = n-fold range 10–25; +++ = n-fold range 25–50; and ++++ = n-fold >50. Indicated gene accession numbers were derived from the GeneBank database.

Real-time reverse transcriptase-polymerase chain reaction (RT-PCR)
The procedures and conditions for real-time RT-PCR using the QuantiTect SYBR Green PCR kit (Qiagen, Valencia, CA) were the same as described elsewhere [8 ]. Primers (Supplemental Data, Table 1 ) were designed using the Primer Express software package (Applied Biosystems, Foster City, CA) and obtained from MWG Biotech (Ebersberg, Germany). Gene expression was normalized with respect to the endogenous housekeeping control gene glyceraldehyde 3-phosphate dehydrogenase. Relative expression differences of respective genes were calculated by using the comparative threshold cycle (CT) method as described [10 ].


View this table:
[in this window]
[in a new window]

 
Table 1. HMEC-1-Characteristic, TNF-Mediated Gene Expression

Flow cytometry
For detection of cell surface molecules on ECs, nonspecific binding was blocked with 1% bovine serum albumin in phosphate-buffered saline (PBS), and immunostaining was performed with mouse monoclonal antibodies (mAb) against intercellular adhesion molecule-1 (ICAM-1; Immunotech, Marseille, France), vascular cell adhesion molecule-1 (Dianova, Hamburg, Germany), CD69, CD137 (Becton Dickinson, Heidelberg, Germany), or corresponding isotype controls and fluorescein isothiocyanate (FITC)-conjugated second-stage reagents (Dianova). An intracellular flow cytometry staining procedure was used for detection of chemokines and cytokines as described earlier [11 ]. Cells were incubated with mAb against fractalkine or IL-1ß (obtained from R&D Systems) or IL-8 or monocyte chemoattractant protein-1 (MCP-1; obtained from Becton Dickinson), which had been diluted in permeabilization buffer (0.1% saponin/1% FCS/PBS). Thereafter, cells were stained with FITC-conjugated second-stage reagents (Dianova). Fluorescence was determined using a FACScan flow cytometer measuring 10,000 ECs, and data were acquired by CellQuest software (Becton Dickinson).


arrow
RESULTS
 
TNF-mediated gene expression profile in HMEC-1
To assess the gene expression profile of TNF-stimulated microvascular ECs, HMEC-1 were cultured according to standard HMEC-1 protocols and exposed to 2 ng/ml TNF for 5 h or left untreated. Total RNA was isolated from HMEC-1 obtained from three independent experiments and processed for DNA microarray hybridization. Restricting the inclusion criteria to a higher-than-2.5-fold increase or down-regulation of gene expression or a considerable on/off switch (for details, refer to Materials and Methods), we identified 86 genes, which were induced upon exposure to TNF, whereas the transcription of only seven genes was down-regulated (the complete and detailed lists of genes are provided as Supplemental Data, Table 2A and 2B ). Most of the induced genes were chemokines/cytokines (12.9%), inflammatory response genes (11.8%), signaling or transcription factors (20.4%), and apoptosis or cell proliferation-related genes (11.8%). Each of the functional groups, "cell surface molecules", "metabolism", "transporter", and "cell structure", comprised 3–8% of the TNF-induced genes in HMEC-1. Our analysis of the TNF-induced gene expression profile in HMEC-1 added 35 molecules to the list of TNF-inducible endothelial genes, which had not been described in ECs before. These include, e.g., CD70, insulin-like growth factor-binding protein 5 (IGFBP5), TNF-{alpha}-induced protein 6 (TNFAIP6), and matrix metalloproteinase 12 (MMP12; Supplemental Data, Table 2A and 2B ).


View this table:
[in this window]
[in a new window]

 
Table 2. HUVEC-Characteristic, TNF-Mediated Gene Expression

TNF-regulated genes specific for HUVEC or HMEC-1
To assess the most reliable gene expression profiles, HMEC-1 and HUVEC [8 ] were cultured under conditions that are generally accepted as the most appropriate for them. We consciously did not chose the same culture conditions, as either of them is always suboptimal with respect to cell vitality for the other EC type, which may alter responses to TNF. Potential bias in expression patterns as a result of culture conditions was avoided by relation of all TNF-induced gene expression data to the corresponding background levels of individual genes detected in the respective, unstimulated EC type. We then compared the spectra of differentially expressed genes in HMEC-1 and HUVEC after stimulation with TNF [8 ], which allowed us to identify genes that were solely regulated in HMEC-1 or HUVEC. The inclusion criteria for such genes were that a gene was regulated in HMEC-1 or HUVEC and that its fold-change regulations over the respective background differed at least twofold between both EC types. Genes that were induced or repressed significantly in both ECs were not taken into account. Analysis of the altogether 93 TNF-regulated genes in HMEC-1 revealed 46 genes (49%) whose transcription was only increased by TNF in HMEC-1 but not in HUVEC (Table 1) . Conversely, we identified 33 genes of altogether 76 up- or down-regulated genes (43%) in HUVEC, which were not regulated significantly by TNF in HMEC-1 (Table 2) . The assignment of these genes to functional groups revealed that considerable differences exist between both EC types with respect to inducibility by TNF. In HUVEC, the major portion of specifically inducible genes belonged to chemokines or cytokines, cell surface molecules, or signaling and transcription factors (Fig. 1 ). In HMEC-1, most genes represented signaling and transcription factors, apoptosis- and cell proliferation-related genes, immune response genes, and cell structure genes (Fig. 1) . Consequently, the most significant differences arise in chemokines/cytokines, adhesion molecules, and cell surface receptors, which predominated strongly in HUVEC as compared with HMEC-1. Conversely, HMEC-1 significantly exceeded HUVEC with respect to the expression of immune response genes and cell structure genes (Fig. 1) .


Figure 1
View larger version (24K):
[in this window]
[in a new window]

 
Figure 1. Differential regulation of gene expression in HUVEC and HMEC-1 after stimulation with TNF. The diagram shows the distribution of genes specifically induced by TNF in HUVEC (solid bars, n=46) and in HMEC-1 (shaded bars, n=33) analyzed by microarray analysis. Individual genes were assigned to functional groups as described in Materials and Methods.

It is surprising that many of the EC type-specific genes were newly identified by this analysis as TNF-inducible, for example, 22 of 40 genes in the case of HMEC-1 (Table 1 and Supplemental Data, Table 2A ).

Confirmation of microarray data by real-time RT-PCR
To confirm the expression pattern of genes, which were inducible in both HMEC-1 and HUVEC, we focused on the chemokine and cytokine repertoire selecting nine chemokines/cytokines and the IL-7 receptor as well as two transcription factors newly identified in HMEC-1 and HUVEC as TNF-inducible for quantitative real-time PCR (Table 3 ). Microarray results of these genes ranged from n-fold regulations of 2.5 (IL-15) to 17.3 (IL-8; Supplemental Data, Table 2A , and ref. [8 ]). RT-PCR was performed in all experiments of each EC type in seven independent approaches altogether. For all 10 genes, the inducibility by TNF could be confirmed in both EC types, thereby validating microarray data (Table 3) .


View this table:
[in this window]
[in a new window]

 
Table 3. TNF-Induced Gene Expression in HUVEC and HMEC-1, As Confirmed by Real-Time RT-PCR

To examine whether EC-dependent differences with respect to the TNF inducibility of distinct genes (Tables 1 and 2) can also be verified by quantitative RT-PCR, we examined exemplary 19 genes, nine cytokines and cytokine receptors, and an additional 10 genes of other functional groups (Table 4 ). Seven of the nine selected cytokines and cytokine receptors were HUVEC-specific genes. For all of them, results of RT-PCR confirmed TNF-induced expression, primarily in HUVEC with the exception of LT-ß (Table 4) . Microarray analysis of LT-ß had shown a strong induction in HUVEC, and it was only weakly switched on in HMEC-1, not fulfilling our strict inclusion criteria for induced genes. RT-PCR rather revealed an induction of LT-ß in HMEC-1 but confirmed the low transcription level in HMEC-1 by CT values, which were seven to eight cycles higher in HMEC-1 than in HUVEC samples. For two additional HUVEC-specific genes, TRAIL and CAR, we also obtained equivalent results by RT-PCR and microarray analysis with a stronger up-regulation of TRAIL and a stronger down-regulation of CAR upon exposure of HUVEC to TNF (Table 4) . Analysis of Cox2 showed a comparable TNF inducibility in both EC types by RT-PCR (Table 4) , although it is listed as a HUVEC-specific gene, according to microarray analysis (Table 2) . It is remarkable that Cox2, like LT-ß, again represents a gene with signal values in HMEC-1, which are below the background level upon microarray analysis. Significant, higher CT values in RT-PCR analysis confirmed the low transcription level in HMEC-1 as compared with HUVEC.


View this table:
[in this window]
[in a new window]

 
Table 4. Differential Regulation of Gene Expression by TNF in HUVEC and HMEC-1, As Confirmed by Real-Time RT-PCR and Microarray Analysis

Regarding HMEC-1-characteristic genes, we examined nine genes by RT-PCR and confirmed array results of stronger TNF inducibility for TL1, angiopoetin-like 4, MMP1, IGFBP5, TNFAIP6, and MMP12. With respect to IL-1ß, CD70, and claudin-1, RT-PCR detected a similar TNF inducibility in both EC types, although microarray analysis predicted a significant up-regulation only in HMEC-1. However, RT-PCR analysis showed that IL-1ß, CD70, and claudin-1 were transcribed at a low level (high CT values). Therefore, low transcription levels appear to be the only clue to discrepancies between microarray and RT-PCR results.

Correlation of gene expression results with protein expression
To verify gene expression at the protein level, intracellular and surface flow cytometry analyses were performed in at least three independent experiments. First, we selected ICAM-1, MCP-1, and IL-8, which are known to be TNF-inducible in ECs. For these genes, inducibility by TNF was confirmed by microarray analysis and verified at the protein level (Fig. 2 ). According to microarray data, IL-1ß is one of the genes that is especially induced in HMEC-1. Intracellular flow cytometry revealed that IL-1ß is up-regulated in HMEC-1 but not in HUVEC, thus confirming microarray data (Fig. 2) .


Figure 2
View larger version (23K):
[in this window]
[in a new window]

 
Figure 2. Validation of gene expression programs in HUVEC and HMEC-1 by flow cytometry. Five genes were selected to confirm their expression at protein level. HMEC-1 and HUVEC were stimulated for 16 h with 2 ng/ml TNF and processed for surface (ICAM-1, CD69) or intracellular flow cytometry (MCP-1, IL-8, IL-1ß). Specific antibody profiles are shown as bold lines and isotype control profiles, as thin lines. Histograms show one of three representative experiments.

CD69 was selected as an example for a HUVEC-specific gene. Flow cytometry clearly demonstrated that CD69 is induced in HUVEC, and expression in HMEC-1 was not detectable, thus again, validating microarray data (Fig. 2) .

The kinetic progression of TNF-regulated gene expression in HUVEC and HMEC-1
To study whether the differences in the TNF-mediated gene expression profiles of HMEC-1 and HUVEC are a result of a different time-course of gene expression, we stimulated both EC types for 1, 3, 5, and 8 h with 2 ng/ml TNF in three independent experiments. We performed quantitative RT-PCRs for a selection of genes, which were designated before to be regulated primarily in HUVEC ("HUVEC -specific genes", Fig. 3A ) or HMEC-1 ("HMEC-1-specific genes", Fig. 3B ) or to be induced significantly by TNF in both EC types after 5 h of TNF stimulation ("HUVEC- and HMEC-1-shared genes", Fig. 3C ). CXCL6 (GCP-2), CXCL2 (Gro-ß), and LT-ß were confirmed to be induced primarily in HUVEC (Fig. 3A) . However, for LT-ß, a significantly higher induction in HUVEC compared with HMEC-1 was not visible before 5 h of TNF stimulation (Fig. 3A) . It might be a result of this dynamics that these experiments now confirmed the HUVEC specificity of LT-ß detected by microarray analysis, which we failed to confirm with the former independent experiments (Table 4) . The time-course of the expression of TL1 shows that a predominant induction in HMEC-1 compared with HUVEC is only true after 5 h of TNF stimulation, whereas the peak of TL1 expression in HUVEC is reached already within 3 h (Fig. 3B) . However, TL1 is the only one of nine genes where a different time-course of gene expression is responsible for our assignments as HMEC-1-specific, HUVEC-specific, or "shared" genes, according to microarray results. With respect to the kinetics of IGFBP5 and MMP12 expression, RT-PCR nicely demonstrates their persistent and predominant induction in HMEC-1 (Fig. 3B) . Furthermore, the assignments of MCP-1, CXCL1, and HIVEP2 to be induced significantly in both EC types hold true over the whole time-dependent course of 8 h (Fig. 3C) .


Figure 3
View larger version (33K):
[in this window]
[in a new window]

 
Figure 3. Kinetic studies of gene expression in HUVEC and HMEC-1 after stimulation with TNF for different time periods. HMEC-1 (open bars) and HUVEC (solid bars) were stimulated for the indicated time periods with 2 ng/ml TNF or left untreated. mRNA expression of selected genes was quantified by real-time RT-PCR. The n-fold value represents the mean of the amount of TNF-induced mRNA expression compared with unstimulated control cells (n=3).

Effects of different culture conditions on differential gene expression in HUVEC and HMEC-1 after TNF stimulation
The standard culture medium of HMEC-1 is supplemented with HC and EGF, whereas the medium routinely used for culture of HUVEC is free of HC and EGF. Both supplements may exhibit inhibitory or growth-stimulating effects on the cell metabolism, which may result in different expression profiles of HMEC-1 and HUVEC. Therefore, in three independent experiments, we cultured HMEC-1 and HUVEC using standard medium (see Materials and Methods) and compared these with HMEC-1 cultured in the absence and HUVEC cultured in the presence of HC and EGF. All EC cultures were stimulated for 5 h with 2 ng/ml TNF or left untreated. Quantitative RT-PCRs were performed for the same selection of genes as for the kinetic studies (Fig. 4 ). Except for LT-ß, which was significantly induced less by TNF in HUVEC cultured with HC and EGF (Fig. 4A) , the addition or omission of HC and EGF did not substantially affect the gene expression patterns observed under standard culture conditions.


Figure 4
View larger version (29K):
[in this window]
[in a new window]

 
Figure 4. Comparison of the influence of different culture conditions on gene expression in HUVEC and HMEC-1, which were cultured under standard conditions (open bars) as described in Materials and Methods or in the absence (HMEC-1, solid bars) or presence of EGF and HC (HUVEC, solid bars). In three independent experiments, ECs were stimulated with 2 ng/ml TNF or left untreated and processed for quantitative RT-PCR. The mean of n-fold induction of gene expression by TNF compared with the control cells is shown.


arrow
DISCUSSION
 
The vascular endothelium is of central importance for generating the initial response to a broad variety of tissue injuries. ECs are crucial for the recruitment of leukocytes and determine the specific composition of an inflammatory infiltrate. In this context, it is widely accepted that the diversity of ECs in vivo is at least partly responsible for the variability between different organs regarding their response to inflammatory stimuli. However, the molecular basis of these different reaction patterns is currently not well defined. The systematic analysis of gene and protein expression profiles is therefore of great importance and may improve our understanding of the variable responses of different ECs to distinct stimuli. HUVEC and HMEC-1 are the most common cell culture systems for analyzing macro- and microvascular ECs in vitro. Although a recent study revealed considerable differences already in the basal gene expression profiles of HUVEC and HMEC-1 [6 ], responses of different EC types to distinct stimuli are often summarized as "EC response" [1 2 3 ]. However, focusing on EC responses to injury and inflammation, basal differences of gene expression are only of interest as far as they influence specific responses of endothelial subtypes to distinct injuries. Systematic analyses of different EC responses to defined stimuli are currently lacking.

With our work, we strive for the detailed comparison of the gene response patterns of HMEC-1 and HUVEC to TNF. In a recent study [8 ], we generated the TNF-mediated gene expression profile of HUVEC. In the present study, we also use oligonucleotide microarray technology for a comprehensive analysis of TNF-regulated gene expression in HMEC-1. To not alter the gene responses of the ECs by suboptimal culture conditions, we consciously used the most appropriate culture condition for each cell type to guarantee optimal cell viability and growth. A potential bias in gene expression patterns as a result of slightly different culture conditions was corrected by relation of all TNF-induced gene expression data to the relevant basal expression levels of each individual gene in both EC types. Thus, we focused our analysis exclusively on TNF-induced genes and excluded differences of basal gene expression patterns, which may be a result of differences in cell cycle or metabolism of these two EC types. Compared with other studies [5 , 7 ], we carefully applied strict quality criteria for a reliable data analysis, which included a sufficient number of independent experiments and the a priori definition of statistical inclusion and exclusion criteria. Consequently, a high reproducibility of statistically validated microarray data by RT-PCR is achieved, confirming 85% of 26 examined genes in HMEC-1. Microarray results, which could not be confirmed by RT-PCR, were mostly related to distinct sensitivities of both methods at low expression levels. Our examples indicated that the inclusion/exclusion criteria used for microarray analysis might miss genes with basal expression levels below the probe set-specific noise. RT-PCR might still detect differences in the expression of such genes as a result of a higher methodological sensitivity. The comprehensive analysis by RT-PCR and direct comparison with microarray data excellently demonstrate the importance of a careful definition of inclusion criteria, which adequately consider gene expression levels. Our study added 35 previously unknown genes to the list of TNF-regulated genes in HMEC-1. These include genes encoding functionally well-characterized proteins such as CD70 [12 ], IGFBP5 [13 14 15 ], TNFAIP6 [16 ], MMP12 [17 ], or human elongation factor-1 [18 , 19 ].

It is surprising that comparing the gene expression profiles of HUVEC and HMEC-1 after TNF stimulation, only less than half of the genes were found to be regulated by TNF in a similar manner in both cell types. Even more striking is the fact that the relative distribution of TNF-regulated genes onto functional groups differs considerably between HMEC-1 and HUVEC ECs. Especially when focusing on chemokines and cytokines, our results are in contrast to previous statements that the expression of cytokines in ECs from various tissues does not differ significantly after stimulation with potent, proinflammatory molecules [1 ]. In HUVEC, TNF stimulation leads to a predominant EC-type, specific expression of chemokines, cytokines, and cell surface molecules. The remarkable, specific induction of genes such as CXCL2 (Gro-{alpha}) [20 ], CXCL6 (GCP-2) [21 ], CSF-1 (GM-CSF) [22 , 23 ], or fractalkine [24 ] in HUVEC points to a higher chemoattractant activity generated after TNF stimulation, especially to neutrophils, monocytes, and activated T lymphocytes. Furthermore, the higher transcription of immunomodulatory genes by HUVEC, such as BMP-2 [25 ] or LT-ß [26 , 27 ], may provide an immunologically different microenvironment for recruited leukocytes. In contrast, the major part of genes induced exclusively by TNF in HMEC-1 is related to apoptosis, cell proliferation, and cell structure genes, which implies that changes in cell structure and EC survival might be especially relevant in these inflammatory microvascular ECs modulating endothelial integrity and barrier function. The most prominent representative of this functional group is VEGF C. The only proinflammatory gene, which is transcribed significantly stronger in HMEC-1 than in HUVEC, is IL-1ß, one of the major acute-phase cytokines responsible for systemic inflammatory responses [1 ].

In the present study, we demonstrate for five selected genes that the expression at the mRNA level correlates well with the expression at the protein level. For strongly induced genes such as MCP-1 and IL-8 microarray analysis, RT-PCR and flow cytometry generated consistent results. In contrast to microarray data, results obtained by RT-PCR suggested an induction of the IL1-ß gene in HMEC-1 as well as in HUVEC; however, the expression level in the latter was low. It is interesting that analysis at the protein level confirmed microarray data of a relevant induction of IL-1ß only in HMEC-1, indicating that the high sensitivity of RT-PCR sometimes amplifies effects at the RNA level, which finally turns out not to be of biological relevance when studying expression at the protein level. Furthermore, we used quantitative RT-PCR analyses to address possible expression differences that might be a result of different kinetic responses in HMEC-1 and HUVEC and to different culture conditions (absence or presence of HC and EGF in the culture media). When selecting three HUVEC-specific genes, three HMEC-1-specific genes, and three HUVEC- and HMEC-1 common genes (Fig. 3) , the recording of RNA expression data over a time period of 8 h validates with only one exception (TL1): the microarray-based assignment to EC type-specific groups regarding expression regulation by TNF. Likewise, RT-PCR analyses of the same selection of genes also demonstrate, with only one exception (LT-ß), that the addition of HC and EGF to the culture medium of HUVEC or the omission of HC and EGF in the HMEC-1 medium does not significantly change the TNF-induced regulation of genes in both EC types as detected by microarray analysis (Fig. 4) .

These results, which support that microarray analyses are a reasonable tool to classify expression profiles in a superior, principal manner and focus on single genes in ECs, always demand the consideration of every condition such as kinetic course of expression, cell type, culture conditions, passage time, and others. Our data clearly indicate that by no means should it be assumed that the response to a stimulus, even to such a strong stimulus such as TNF, is roughly the same in distinct subtypes of ECs. The response to TNF stimulation is highly specific for HUVEC and HMEC-1. It has therefore to be considered that there is a much higher diversity of ECs in vivo, which may result in even greater differences of distinct tissue-specific ECs to inflammatory stimuli in vivo.

In summary, our study generates a comprehensive, TNF-mediated gene expression profile in HMEC-1 and characterized in detail the considerably different responses of HMEC-1 and HUVEC to TNF. Our results sensitize to a more cautious interpretation of in vitro data, which should result in a stronger consideration of EC type-specific effects. Conversely, the basis for a selective manipulation of EC subtypes in different inflammatory diseases may be provided by defining EC type-specific expression patterns to distinct, inflammatory stimuli.


arrow
ACKNOWLEDGEMENTS
 
This work was supported by the Deutsche Forschungsgemeinschaft (DFG) Grant GO811/1-3 to M. G. and the Interdisciplinary Clinical Research Center of the University of Muenster Grant Fo2/26/04 to J. R. D. V. and M. G. contributed equally to this work.

Received September 26, 2005; revised January 17, 2006; accepted February 22, 2006.


arrow
REFERENCES
 
    1
  1. Krishnaswamy, G., Kelley, J., Yerra, L., Smith, J. K., Chi, D. S. (1999) Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease J. Interferon Cytokine Res. 19,91-104[CrossRef][Medline]
  2. 2
  3. Mantovani, A., Garlanda, C., Introna, M., Vecchi, A. (1998) Regulation of endothelial cell function by pro- and anti-inflammatory cytokines Transplant. Proc. 30,4239-4243[CrossRef][Medline]
  4. 3
  5. Peters, K., Unger, R. E., Brunner, J., Kirkpatrick, C. J. (2003) Molecular basis of endothelial dysfunction in sepsis Cardiovasc. Res. 60,49-57[Abstract/Free Full Text]
  6. 4
  7. Lidington, E. A., Moyes, D. L., McCormack, A. M., Rose, M. L. (1999) A comparison of primary endothelial cells and endothelial cell lines for studies of immune interactions Transpl. Immunol. 7,239-246[CrossRef][Medline]
  8. 5
  9. Kallmann, B. A., Wagner, S., Hummel, V., Buttmann, M., Bayas, A., Tonn, J. C., Rieckmann, P. (2002) Characteristic gene expression profile of primary human cerebral endothelial cells FASEB J. 16,589-591[Free Full Text]
  10. 6
  11. Chi, J. T., Chang, H. Y., Haraldsen, G., Jahnsen, F. L., Troyanskaya, O. G., Chang, D. S., Wang, Z., Rockson, S. G., van de Rijn, M., Botstein, D., Brown, P. O. (2003) Endothelial cell diversity revealed by global expression profiling Proc. Natl. Acad. Sci. USA 100,10623-10628[Abstract/Free Full Text]
  12. 7
  13. Franzen, B., Duvefelt, K., Jonsson, C., Engelhardt, B., Ottervald, J., Wickman, M., Yang, Y., Schuppe-Koistinen, I. (2003) Gene and protein expression profiling of human cerebral endothelial cells activated with tumor necrosis factor-{alpha} Brain Res. Mol. Brain Res. 115,130-146[Medline]
  14. 8
  15. Viemann, D., Goebeler, M., Schmid, S., Klimmek, K., Sorg, C., Ludwig, S., Roth, J. (2004) Transcriptional profiling of IKK2/NF-{kappa} B- and p38 MAP kinase-dependent gene expression in TNF-{alpha}-stimulated primary human endothelial cells Blood 103,3365-3373[Abstract/Free Full Text]
  16. 9
  17. Denk, A., Goebeler, M., Schmid, S., Berberich, I., Ritz, O., Lindemann, D., Ludwig, S., Wirth, T. (2001) Activation of NF-{kappa} B via the I{kappa} B kinase complex is both essential and sufficient for proinflammatory gene expression in primary endothelial cells J. Biol. Chem. 276,28451-28458[Abstract/Free Full Text]
  18. 10
  19. Liu, W., Saint, D. A. (2002) A new quantitative method of real time reverse transcription polymerase chain reaction assay based on simulation of polymerase chain reaction kinetics Anal. Biochem. 302,52-59[CrossRef][Medline]
  20. 11
  21. Goebeler, M., Gillitzer, R., Kilian, K., Utzel, K., Brocker, E. B., Rapp, U. R., Ludwig, S. (2001) Multiple signaling pathways regulate NF-{kappa}B-dependent transcription of the monocyte chemoattractant protein-1 gene in primary endothelial cells Blood 97,46-55[Abstract/Free Full Text]
  22. 12
  23. Jacquot, S. (2000) CD27/CD70 interactions regulate T dependent B cell differentiation Immunol. Res. 21,23-30[CrossRef][Medline]
  24. 13
  25. Butt, A. J., Dickson, K. A., McDougall, F., Baxter, R. C. (2003) Insulin-like growth factor-binding protein-5 inhibits the growth of human breast cancer cells in vitro and in vivo J. Biol. Chem. 278,29676-29685[Abstract/Free Full Text]
  26. 14
  27. Pilewski, J. M., Liu, L., Henry, A. C., Knauer, A. V., Feghali-Bostwick, C. A. (2005) Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition Am. J. Pathol. 166,399-407[Abstract/Free Full Text]
  28. 15
  29. Xu, Q., Yan, B., Li, S., Duan, C. (2004) Fibronectin binds insulin-like growth factor-binding protein 5 and abolishes its ligand-dependent action on cell migration J. Biol. Chem. 279,4269-4277[Abstract/Free Full Text]
  30. 16
  31. Milner, C. M., Day, A. J. (2003) TSG-6: a multifunctional protein associated with inflammation J. Cell Sci. 116,1863-1873[Abstract/Free Full Text]
  32. 17
  33. Nagase, H., Woessner, J. F., Jr (1999) Matrix metalloproteinases J. Biol. Chem. 274,21491-21494[Free Full Text]
  34. 18
  35. Law, S. F., Zhang, Y. Z., Klein-Szanto, A. J., Golemis, E. A. (1998) Cell cycle-regulated processing of HEF1 to multiple protein forms differentially targeted to multiple subcellular compartments Mol. Cell. Biol. 18,3540-3551[Abstract/Free Full Text]
  36. 19
  37. Suzuki, T., Nakamoto, T., Ogawa, S., Seo, S., Matsumura, T., Tachibana, K., Morimoto, C., Hirai, H. (2002) MICAL, a novel CasL interacting molecule, associates with vimentin J. Biol. Chem. 277,14933-14941[Abstract/Free Full Text]
  38. 20
  39. Geiser, T., Dewald, B., Ehrengruber, M. U., Clark-Lewis, I., Baggiolini, M. (1993) The interleukin-8-related chemotactic cytokines GRO {alpha}, GRO ß, and GRO {gamma} activate human neutrophil and basophil leukocytes J. Biol. Chem. 268,15419-15424[Abstract/Free Full Text]
  40. 21
  41. Van Damme, J., Wuyts, A., Froyen, G., Van Coillie, E., Struyf, S., Billiau, A., Proost, P., Wang, J. M., Opdenakker, G. (1997) Granulocyte chemotactic protein-2 and related CXC chemokines: from gene regulation to receptor usage J. Leukoc. Biol. 62,563-569[Abstract]
  42. 22
  43. Shang, X. Z., Issekutz, A. C. (1999) Enhancement of monocyte transendothelial migration by granulocyte-macrophage colony-stimulating factor: requirement for chemoattractant and CD11a/CD18 mechanisms Eur. J. Immunol. 29,3571-3582[CrossRef][Medline]
  44. 23
  45. Cheng, S. S., Lai, J. J., Lukacs, N. W., Kunkel, S. L. (2001) Granulocyte-macrophage colony stimulating factor up-regulates CCR1 in human neutrophils J. Immunol. 166,1178-1184[Abstract/Free Full Text]
  46. 24
  47. Umehara, H., Bloom, E. T., Okazaki, T., Nagano, Y., Yoshie, O., Imai, T. (2004) Fractalkine in vascular biology: from basic research to clinical disease Arterioscler. Thromb. Vasc. Biol. 24,34-40[Abstract/Free Full Text]
  48. 25
  49. Willette, R. N., Gu, J. L., Lysko, P. G., Anderson, K. M., Minehart, H., Yue, T. (1999) BMP-2 gene expression and effects on human vascular smooth muscle cells J. Vasc. Res. 36,120-125[CrossRef][Medline]
  50. 26
  51. Armengol, M. P., Cardoso-Schmidt, C. B., Fernandez, M., Ferrer, X., Pujol-Borrell, R., Juan, M. (2003) Chemokines determine local lymphoneogenesis and a reduction of circulating CXCR4+ T and CCR7 B and T lymphocytes in thyroid autoimmune diseases J. Immunol. 170,6320-6328[Abstract/Free Full Text]
  52. 27
  53. Drayton, D. L., Chan, K., Lesslauer, W., Lee, J., Ying, X. Y., Ruddle, N. H. (2002) Lymphocyte traffic in lymphoid organ neogenesis: differential roles of Lt{alpha} and LT{alpha}ß Adv. Exp. Med. Biol. 512,43-48[Medline]



This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Chaudhury, M. Zakkar, J. Boyle, S. Cuhlmann, K. van der Heiden, L. A. Luong, J. Davis, A. Platt, J. C. Mason, R. Krams, et al.
c-Jun N-Terminal Kinase Primes Endothelial Cells at Atheroprone Sites for Apoptosis
Arterioscler Thromb Vasc Biol, March 1, 2010; 30(3): 546 - 553.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
W. Mostertz, M. Stevenson, C. Acharya, I. Chan, K. Walters, W. Lamlertthon, W. Barry, J. Crawford, J. Nevins, and A. Potti
Age- and Sex-Specific Genomic Profiles in Non-Small Cell Lung Cancer
JAMA, February 10, 2010; 303(6): 535 - 543.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
E. Bruegmann, R. Gruemmer, J. Neulen, and K. Motejlek
Regulation of soluble vascular endothelial growth factor receptor 1 secretion from human endothelial cells by tissue inhibitor of metalloproteinase 1
Mol. Hum. Reprod., November 1, 2009; 15(11): 749 - 756.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. Anguiano, S. A. Tuchman, C. Acharya, K. Salter, C. Gasparetto, F. Zhan, M. Dhodapkar, J. Nevins, B. Barlogie, J. D. Shaughnessy Jr, et al.
Gene Expression Profiles of Tumor Biology Provide a Novel Approach to Prognosis and May Guide the Selection of Therapeutic Targets in Multiple Myeloma
J. Clin. Oncol., September 1, 2009; 27(25): 4197 - 4203.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Johnson
TNF-induced activation of pulmonary microvessel endothelial cells: a role for GSK3{beta}
Am J Physiol Lung Cell Mol Physiol, April 1, 2009; 296(4): L700 - L709.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Sakakibara, C. A. Pise-Masison, J. N. Brady, and G. Tosato
Gene Regulation and Functional Alterations Induced by Kaposi's Sarcoma-Associated Herpesvirus-Encoded ORFK13/vFLIP in Endothelial Cells
J. Virol., March 1, 2009; 83(5): 2140 - 2153.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Marmon, J. Hinchey, P. Oh, M. Cammer, C. J. de Almeida, L. Gunther, C. S. Raine, and M. P. Lisanti
Caveolin-1 Expression Determines the Route of Neutrophil Extravasation through Skin Microvasculature
Am. J. Pathol., February 1, 2009; 174(2): 684 - 692.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Mori, R. E. Rempel, J. T. Chang, G. Yao, A. S. Lagoo, A. Potti, A. Bild, and J. R. Nevins
Utilization of Pathway Signatures to Reveal Distinct Types of B Lymphoma in the E{micro}-myc Model and Human Diffuse Large B-Cell Lymphoma
Cancer Res., October 15, 2008; 68(20): 8525 - 8534.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
E. R. Andrechek, S. Mori, R. E. Rempel, J. T. Chang, and J. R. Nevins
Patterns of cell signaling pathway activation that characterize mammary development
Development, July 15, 2008; 135(14): 2403 - 2413.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
C. R. Acharya, D. S. Hsu, C. K. Anders, A. Anguiano, K. H. Salter, K. S. Walters, R. C. Redman, S. A. Tuchman, C. A. Moylan, S. Mukherjee, et al.
Gene Expression Signatures, Clinicopathological Features, and Individualized Therapy in Breast Cancer
JAMA, April 2, 2008; 299(13): 1574 - 1587.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. A. O'Brien, M. A. Richardson, D. T. Berg, B. Gerlitz, A. Gupta, and B. W. Grinnell
The Puzzling Role of TRAIL in Endothelial Cell Biology
Arterioscler Thromb Vasc Biol, February 1, 2008; 28(2): e5 - e6.
[Full Text] [PDF]


Home page
J. Immunol.Home page
D. Viemann, M. Schmidt, K. Tenbrock, S. Schmid, V. Muller, K. Klimmek, S. Ludwig, J. Roth, and M. Goebeler
The Contact Allergen Nickel Triggers a Unique Inflammatory and Proangiogenic Gene Expression Pattern via Activation of NF-{kappa}B and Hypoxia-Inducible Factor-1{alpha}
J. Immunol., March 1, 2007; 178(5): 3198 - 3207.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Supplemental Data for jlb.0905530
Right arrow All Versions of this Article:
jlb.0905530v1
80/1/174    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Viemann, D.
Right arrow Articles by Roth, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Viemann, D.
Right arrow Articles by Roth, J.